Search
Acute Bacterial Skin and Skin Structure Infection (ABSSSI) caused by Streptococcus Pyogenes Infection
go.drugbank.com/conditions/DBCOND0165659Drugs: Ceftobiprole medocarilSynonyms: Acute Bacterial Skin and Skin Structure Infection (ABSSSI) caused by Streptococcus Pyogenes InfectionPerfluorooctane
go.drugbank.com/drugs/DB15997InvestigationalProducts: SONAZOID POWDER AND SOLVENT FOR DISPERSION FOR INJECTION 16 MICROLITRE PER VIALBortezomib
go.drugbank.com/drugs/DB00188ApprovedInvestigational, and solid tumours. … Bortezomib is a dipeptide boronic acid derivative and proteasome inhibitor used to treat multiple myeloma and mantle cell lymphoma.
Categories: Antineoplastic and Immunomodulating AgentsProducts: MYBORTE 1.0mg (Bortezomib Powder for Solution for Injection 1.0mg/vial)Tenofovir
go.drugbank.com/drugs/DB14126Investigational[A37693] The antiviral activities of tenofovir were first reported in 1993 and this agent was commercially available since 2008 in the form of [tenofovir disoproxil] and [tenofovir alafenamide] in order … [A37693] In the most strict sense and due to the fact that it presents a phosphate group bound to the nitrogenous base, it is determined as an actual nucleotide analog.
Categories: Tenofovir and prodrugsSynonyms: Tenofovir (anh.)Acute Bacterial Skin and Skin Structure Infection (ABSSSI) caused by Klebsiella Pneumoniae Infection
go.drugbank.com/conditions/DBCOND0165660Drugs: Ceftobiprole medocarilSynonyms: Acute Bacterial Skin and Skin Structure Infection (ABSSSI) caused by Klebsiella Pneumoniae InfectionEye discharge
go.drugbank.com/conditions/DBCOND0009896Drugs: SulfamerazineSynonyms: Discharge from eye (finding)Angelica dahurica root
go.drugbank.com/drugs/DB14255InvestigationalIt is not an approved drug.
Products: Gongjinhyang Qi and Jin Eye(3-Formyl-but-3-Enyl)-Phosphonic Acid
go.drugbank.com/drugs/DB03211ExperimentalSynonyms: (3-Formyl-but-3-Enyl)-Phosphonic AcidLanreotide
go.drugbank.com/drugs/DB06791ApprovedInvestigationalLanreotide is manufactured by the company, _Ipsen Pharmaceuticals_ as lanreotide acetate, and marketed as _Somatuline_. … It is approved in several countries worldwide, including the United Kingdom, Australia, and Canada. Lanreotide was first approved for use in the United States by the FDA on August 30, 2007.
Categories: Pituitary and Hypothalamic Hormones and Analogues, Sex Hormones and InsulinsProducts: Somatuline Autogel 120mg, prolonged-release solution for injection in a pre-filled syringe, Somatuline Autogel 60mg, prolonged-release solution for injection in a pre-filled syringeUrethane
go.drugbank.com/drugs/DB04827ApprovedWithdrawnUrethane, formerly marketed as an inactive ingredient in Profenil injection, was determined to be carcinogenic and was removed from the Canadian, US, and UK markets in 1963.